(Q37978806)

English

Cannabinoids and atherosclerotic coronary heart disease

scientific article published on 25 January 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Cannabinoids and atherosclerotic coronary heart disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

0 references

atherosclerosis

1 reference

based on heuristic

inferred from title

Rajesh Sachdeva

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6652534&resulttype=core&format=json

15 May 2020

author name string

Sandeep Singla

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6652534&resulttype=core&format=json

15 May 2020

Jawahar L Mehta

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6652534&resulttype=core&format=json

15 May 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

25 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Clinical Cardiology

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6652534&resulttype=core&format=json

15 May 2020

35

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6652534&resulttype=core&format=json

15 May 2020

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6652534&resulttype=core&format=json

15 May 2020

329-335

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6652534&resulttype=core&format=json

15 May 2020

Cannabinoids as therapeutic agents in cardiovascular disease: a tale of passions and illusions

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

Cannabinoid receptors in atherosclerosis.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

CB2-receptor stimulation attenuates TNF-alpha-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

The procoagulatory effects of delta-9-tetrahydrocannabinol in human platelets.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

(Endo)cannabinoids mediate different Ca2+ entry mechanisms in human bronchial epithelial cells

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

Evidence for novel cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

PPAR-gamma: a nuclear receptor with affinity for cannabinoids

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

The cannabinoid system and immune modulation

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

Delta 9-Tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

Towards a therapeutic use of selective CB2 cannabinoid receptor ligands for atherosclerosis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

Activated endocannabinoid system in coronary artery disease and antiinflammatory effects of cannabinoid 1 receptor blockade on macrophages

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

Rimonabant, a selective cannabinoid CB1 receptor antagonist, inhibits atherosclerosis in LDL receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

Functional CB1 cannabinoid receptors in human vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

Cannabinoid-1 receptor activation induces reactive oxygen species-dependent and -independent mitogen-activated protein kinase activation and cell death in human coronary artery endothelial cells

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

Activation of cannabinoid CB2 receptor ameliorates atherosclerosis associated with suppression of adhesion molecules

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

Role of oxidative modifications in atherosclerosis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

Cannabidiol-2',6'-dimethyl ether, a cannabidiol derivative, is a highly potent and selective 15-lipoxygenase inhibitor.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

In vivo action of 15-lipoxygenase in early stages of human atherogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

Role of activated endocannabinoid system in regulation of cellular cholesterol metabolism in macrophages

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

Cannabinoid 1 receptor blockade reduces atherosclerosis with enhances reverse cholesterol transport

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

Rimonabant is a dual inhibitor of acyl CoA:cholesterol acyltransferases 1 and 2.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

CB2 cannabinoid receptor agonists attenuate TNF-alpha-induced human vascular smooth muscle cell proliferation and migration

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

Cannabinoid CB1 receptor inhibition decreases vascular smooth muscle migration and proliferation

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

CB1 receptor inhibition leads to decreased vascular AT1 receptor expression, inhibition of oxidative stress and improved endothelial function

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

Activation of cannabinoid receptors decreases the area of ischemic myocardial necrosis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

CB(2) cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

The cannabinoid receptor type 2 promotes cardiac myocyte and fibroblast survival and protects against ischemia/reperfusion-induced cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

Endocannabinoids protect the rat isolated heart against ischaemia

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

Effect of smoking marihuana and of a high-nicotine cigarette on angina pectoris

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

An exploratory prospective study of marijuana use and mortality following acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

Triggering myocardial infarction by marijuana

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

2-arachidonyl glycerol activates platelets via conversion to arachidonic acid and not by direct activation of cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

The inhibitory effects of cannabinoids, the active constituents of Cannabis sativa L. on human and rabbit platelet aggregation

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

Keep off the grass: marijuana use and acute cardiovascular events.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

Effect of rimonabant on carotid intima-media thickness (CIMT) progression in patients with abdominal obesity and metabolic syndrome: the AUDITOR Trial

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

Cannabinoid receptor type 2 (CB2) deficiency alters atherosclerotic lesion formation in hyperlipidemic Ldlr-null mice

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

Particulate air pollution as a risk factor for ST-segment depression in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

Urban particulate matter air pollution is associated with subclinical atherosclerosis: results from the HNR (Heinz Nixdorf Recall) study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.21962

21 January 2018

Inflammation in atherosclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22278660

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medical marijuana and the law

1 reference

https://pubmed.ncbi.nlm.nih.gov/22278660

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of cannabinoid receptors in human kidney

1 reference

https://pubmed.ncbi.nlm.nih.gov/22278660

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

WIN55212-2 ameliorates atherosclerosis associated with suppression of pro-inflammatory responses in ApoE-knockout mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/22278660

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The absolute configuration of δ1-tetrahydrocannabinol, the major active constituent of hashish

1 reference

https://pubmed.ncbi.nlm.nih.gov/22278660

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of oral delta-9-tetrahydrocannabinol on coagulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22278660

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of smoking marihuana on left ventricular performance and plasma norepinephrine: studies in normal men

1 reference

https://pubmed.ncbi.nlm.nih.gov/22278660

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/CLC.21962

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6652534&resulttype=core&format=json

15 May 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6652534&resulttype=core&format=json

15 May 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6652534&resulttype=core&format=json

15 May 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37978806&oldid=2110710334"